Literature DB >> 11953383

Diversity of the metalloprotease toxin produced by enterotoxigenic Bacteroides fragilis.

Shaoguang Wu1, Lawrence A Dreyfus, Art O Tzianabos, Chika Hayashi, Cynthia L Sears.   

Abstract

Enterotoxigenic Bacteroides fragilis (ETBF) strains produce a 20-kDa zinc metalloprotease toxin (BFT) associated with diarrheal disease of animals, young children, and adults. BFT stimulates secretion in intestinal loops in vivo and modifies epithelial cell morphology in vitro. The B. fragilis toxin (bft) gene from ETBF strain 86-5443-2-2 (piglet; bft-2) revealed significant nucleotide and predicted amino acid differences when compared to the bft gene from ETBF strain VPI 13784 (lamb; bft-1). This study compares BFT-1 and BFT-2, respectively, produced by ETBF strains VPI 13784 and 86-5443-2-2 purified using the Van Tassell method (38) and a modified purification scheme described herein. Multiple differences in the protein toxins produced by these ETBF strains were identified. First, purified BFT-1 eluted from a high-resolution anion-exchange column (Mono Q) at 0.22 +/- 0.005 M NaC1 versus 0.18 +/- 0.001 M NaC1 for BFT-2 (P < 0.001). Second, BFT-1 and BFT-2 exhibited different electrophoretic mobilities on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and reverse-phase fast protein liquid chromatography. Third, each BFT reacted with greater specificity to homologous rather than heterologous antisera. Fourth, BFT-2 had modest, but consistently, greater biological activity than BFT-1 when tested on HT29/C1 cells (P < or = 0.01). Together, these data indicate that these ETBF strains produce two distinct isotypes of BFT, termed BFT-1 (VPI 13784 BFT) and BFT-2 (86-5443-2-2 BFT) to recognize the order in which the proteins were purified and genetic sequences identified. The modified purification scheme described in this report yields about two to three times more purified BFT protein than previous protocols and is less time consuming.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953383      PMCID: PMC127897          DOI: 10.1128/IAI.70.5.2463-2471.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.

Authors:  A Pantosti; A O Tzianabos; A B Onderdonk; D L Kasper
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Prevalence of enterotoxigenic Bacteroides fragilis in adult patients with diarrhea and healthy controls.

Authors:  G Zhang; B Svenungsson; A Kärnell; A Weintraub
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

3.  Production of antisera against the enterotoxin of Bacteroides fragilis and their use in a cytotoxicity neutralization assay of HT-29 cells.

Authors:  R L Van Tassel; D M Lyerly; T D Wilkins
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

4.  Enterotoxigenic Bacteroides fragilis: epidemiologic studies of its role as a human diarrhoeal pathogen.

Authors:  R B Sack; L L Myers; J Almeido-Hill; D S Shoop; W C Bradbury; R Reid; M Santosham
Journal:  J Diarrhoeal Dis Res       Date:  1992-03

5.  Determination of the concentrations of oligosaccharides, complex type carbohydrates, and glycoproteins using the phenol-sulfuric acid method.

Authors:  S K Saha; C F Brewer
Journal:  Carbohydr Res       Date:  1994-02-17       Impact factor: 2.104

6.  Purification and characterization of an enterotoxin from Bacteroides fragilis.

Authors:  R L Van Tassell; D M Lyerly; T D Wilkins
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides.

Authors:  A O Tzianabos; A Pantosti; H Baumann; J R Brisson; H J Jennings; D L Kasper
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

8.  Bacteroides fragilis strains express multiple capsular polysaccharides.

Authors:  A Pantosti; A O Tzianabos; B G Reinap; A B Onderdonk; D L Kasper
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

9.  Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology.

Authors:  C S Weikel; F D Grieco; J Reuben; L L Myers; R B Sack
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  Diarrhea associated with enterotoxigenic Bacteroides fragilis in foals.

Authors:  L L Myers; D S Shoop; T D Byars
Journal:  Am J Vet Res       Date:  1987-11       Impact factor: 1.156

View more
  22 in total

1.  Mutation of the zinc-binding metalloprotease motif affects Bacteroides fragilis toxin activity but does not affect propeptide processing.

Authors:  Augusto A Franco; Simy L Buckwold; Jai W Shin; Miguel Ascon; Cynthia L Sears
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  The C-terminal region of Bacteroides fragilis toxin is essential to its biological activity.

Authors:  Cynthia L Sears; Simy L Buckwold; Jai W Shin; Augusto A Franco
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

3.  Quantitative detection of enterotoxigenic Bacteroides fragilis subtypes isolated from children with and without diarrhea.

Authors:  V R C Merino; V Nakano; C Liu; Y Song; S M Finegold; M J Avila-Campos
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

4.  Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.

Authors:  Andrew C Goodwin; Christina E Destefano Shields; Shaoguang Wu; David L Huso; XinQun Wu; Tracy R Murray-Stewart; Amy Hacker-Prietz; Shervin Rabizadeh; Patrick M Woster; Cynthia L Sears; Robert A Casero
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

5.  Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells.

Authors:  Liam Chung; Erik Thiele Orberg; Abby L Geis; June L Chan; Kai Fu; Christina E DeStefano Shields; Christine M Dejea; Payam Fathi; Jie Chen; Benjamin B Finard; Ada J Tam; Florencia McAllister; Hongni Fan; Xinqun Wu; Sudipto Ganguly; Andriana Lebid; Paul Metz; Sara W Van Meerbeke; David L Huso; Elizabeth C Wick; Drew M Pardoll; Fengyi Wan; Shaoguang Wu; Cynthia L Sears; Franck Housseau
Journal:  Cell Host Microbe       Date:  2018-02-01       Impact factor: 21.023

6.  Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway.

Authors:  Shaoguang Wu; Jan Powell; Nes Mathioudakis; Sheryl Kane; Ellen Fernandez; Cynthia L Sears
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Purification and characterization of two distinct metalloproteases secreted by the entomopathogenic bacterium Photorhabdus sp. strain Az29.

Authors:  C M Cabral; A Cherqui; A Pereira; N Simões
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

8.  Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice.

Authors:  Ki-Jong Rhee; Shaoguang Wu; Xinqun Wu; David L Huso; Baktiar Karim; Augusto A Franco; Shervin Rabizadeh; Jonathan E Golub; Lauren E Mathews; Jai Shin; R Balfour Sartor; Douglas Golenbock; Abdel R Hamad; Christine M Gan; Franck Housseau; Cynthia L Sears
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

9.  Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea.

Authors:  Cynthia L Sears; Salequl Islam; Amit Saha; Maleka Arjumand; Nur Haque Alam; A S G Faruque; M A Salam; Jai Shin; David Hecht; Andrej Weintraub; R Bradley Sack; Firdausi Qadri
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

Review 10.  Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis.

Authors:  Cynthia L Sears; Abby L Geis; Franck Housseau
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.